For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.
COPD Morning Symptoms: Why Not a Treatment Goal?
A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.
Among Never-smokers, Black Women at Highest Risk for COPD
Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.
Prognostic Power of the BCSS in Severe COPD
The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.
Symptom Clusters and Biomarkers in COPD
The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.
Long-Term Oxygen in COPD No Better Than None
A new study sought to clarify conflicting findings on the impact of supplemental oxygen on exacerbations, hospitalization, and quality of life.
Amplified COPD Screening for Primary Care
A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.
Indoor Heat, Air Quality Increase Symptoms in COPD
The combination of heat and in-home air pollutants is dangerous, but also modifiable, say authors of a new study.
5 New Things about COPD
Identifying risk, a promising mortality biomarker, and a new app for study recruitment—just a few of the latest developments in COPD research and patient care.
By clicking Accept, you agree to become a member of the UBM Medica Community.